openPR Logo
Press release

Amyotrophic Lateral Sclerosis Market Opportunities, Challenges, and Growth Forecast by 2024-2031 | Sanofi, Brainstorm Cell Therapeutics, Biogen, Bausch Health

11-11-2024 09:55 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Amyotrophic Lateral Sclerosis Market || 2024-2031

Amyotrophic Lateral Sclerosis Market || 2024-2031

The Amyotrophic Lateral Sclerosis Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/amyotrophic-lateral-sclerosis-market

What is the projected growth rate (CAGR) of the Global Amyotrophic Lateral Sclerosis market from 2024 to 2031, and what is the market value expected to change by 2031?

The Global Amyotrophic Lateral Sclerosis Market size reached USD 0.7 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 1.0 billion by 2031. The global amyotrophic lateral sclerosis market is expected to exhibit a CAGR of 5.1% during the forecast period (2024-2031).

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord. It causes the gradual deterioration of motor neurons, which are responsible for controlling voluntary muscles. As the disease progresses, individuals with ALS experience muscle weakness, loss of coordination, and paralysis. In the later stages, ALS can impair the ability to speak, swallow, and breathe. The exact cause of ALS is unknown in most cases, though it may involve genetic and environmental factors. There is currently no cure, but treatments aim to manage symptoms and improve quality of life.

Key Developments:

❁ On June 14, 2023, Coya Therapeutics, Inc., a clinical-stage biotechnology company focused on developing biologics to enhance Treg function, announced the appointment of Dr. Michelle Frazier, Ph.D., as Senior Vice President of Regulatory Affairs. Dr. Frazier will apply her regulatory and CMC expertise to oversee all of Coya's regulatory submissions, including the upcoming IND submission for COYA 302, aimed at treating Amyotrophic Lateral Sclerosis (ALS).

List of the Key Players in the Amyotrophic Lateral Sclerosis Market:

Sanofi, Brainstorm Cell Therapeutics, Biogen, Bausch Health, Roche, Ionis Pharmaceuticals, Apotex, Mylan Pharma, Sun Pharma, Orion Pharmaceuticals, ViroMed, Mitsubishi Tanabe Pharma America, AB Science and Orphazyme.

Research Process:

Both primary and secondary data sources have been used in the global Amyotrophic Lateral Sclerosis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Amyotrophic Lateral Sclerosis Market:

By Drug: Rilutek (Riluzole), Edaravone (Radicava), Others

By Treatment Type: Physical therapy, Speech Therapy, Medication, Respiratory Therapy, Others

By End-User: Diagnostic Centers, Hospitals, Clinics, Others

Regional Breakout:

The global Amyotrophic Lateral Sclerosis Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

✫ North America (U.S., Canada, Mexico)

✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

✫ South America (Colombia, Brazil, Argentina, Rest of South America)

✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=amyotrophic-lateral-sclerosis-market

This Report Unveils:

✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.

✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.

✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.

✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.

✔ Identify high-potential niche segments and regions poised for significant expansion.

✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.

✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Amyotrophic Lateral Sclerosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Amyotrophic Lateral Sclerosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Amyotrophic Lateral Sclerosis market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Amyotrophic Lateral Sclerosis market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/amyotrophic-lateral-sclerosis-market

Frequently Asked Questions

☞ What is the expected growth rate of the global Amyotrophic Lateral Sclerosis market for the forecast period?

☞ What are the key driving factors that are responsible to shape the fate of the Amyotrophic Lateral Sclerosis market during the forecast period?

☞ What will be the overall size of the market during the analysis period?

☞ What are the prominent market trends which influence the development of the Amyotrophic Lateral Sclerosis market across various regions?

☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Amyotrophic Lateral Sclerosis market?

☞ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Amyotrophic Lateral Sclerosis Market Opportunities, Challenges, and Growth Forecast by 2024-2031 | Sanofi, Brainstorm Cell Therapeutics, Biogen, Bausch Health here

News-ID: 3727325 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Chemical Distribution Market (2026) | Shaping the Future of Global Industrial Supply Chains, Growth, Trends, and Emerging Industry Players
Chemical Distribution Market (2026) | Shaping the Future of Global Industrial Su …
chemical distribution industry serves as a vital intermediary in the global supply chain, bridging chemical manufacturers and end-use sectors by managing complex logistics, regulatory compliance, and value-added services. United States: Recent Industry Developments ✅ Jan 2026: Univar Solutions expanded its specialty chemicals distribution network in the U.S. to meet rising demand in coatings and adhesives. ✅ Dec 2025: Brenntag acquired a regional distributor in Texas to strengthen its portfolio in industrial chemicals. ✅ Nov
Ammonia Cracking Catalysts Market to hit $ 136.6 million by 2031 | Major Players 2026 - Johnson Matthey, Clariant, Heraeus Group, Dorf Ketal
Ammonia Cracking Catalysts Market to hit $ 136.6 million by 2031 | Major Players …
The Ammonia Cracking Catalysts Market reached US$ 6.8 million in 2022 and is projected to reach US$ 136.6 million by 2031, growing at a remarkable CAGR of 45.5% during the forecast period 2025-2032. DataM Intelligence unveils exclusive insights into the Global Ammonia Cracking Catalysts Market 2026, highlighting the increasing adoption of hydrogen production technologies, the rise of green hydrogen initiatives, and the development of advanced catalytic materials for ammonia decomposition across
HVDC Transmission Market Analysis (2026): Key Players, Forecast, and Emerging Opportunities
HVDC Transmission Market Analysis (2026): Key Players, Forecast, and Emerging Op …
High-Voltage Direct Current (HVDC) transmission remains a trending topic in Japan's energy sector, driven by the need for grid modernization, renewable integration (especially offshore wind), frequency conversion between eastern (50 Hz) and western (60 Hz) grids, and interconnections for stable power supply amid decarbonization goals (net-zero by 2050). Japan's HVDC market emphasizes underground/submarine cables, Voltage Source Converter (VSC) tech for flexibility, and efficiency in long-distance/low-loss transmission. United States: Recent Industry Developments ✅
Direct Air Capture Market to Reach US$ 3,008.30 Million by 2032 | North America leads with 35% share | Top Companies - Climeworks, Carbon Engineering ULC., Global Thermostat
Direct Air Capture Market to Reach US$ 3,008.30 Million by 2032 | North America …
As per DataM intelligence research report "Global Direct Air Capture (DUS$65.88AC) Market reached US$ 65.88 million in 2024 and is expected to reach US$3,008.30 million by 2032, growing with a CAGR of 61.23% during the forecast period 2025-2032" The market is growing with rising focus on carbon removal technologies. Direct air capture systems remove CO2 directly from the atmosphere. Climate goals and carbon neutrality targets drive adoption. Download your exclusive sample report

All 5 Releases


More Releases for Amyotrophic

Amyotrophic Lateral Sclerosis Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "Amyotrophic Lateral Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It covers the Amyotrophic Lateral Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Amyotrophic Lateral Sclerosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Amyotrophic Lateral Sclerosis Pipeline Insights and Treatment Drugs 2024 (Update …
DelveInsight's, "Amyotrophic Lateral Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It covers the Amyotrophic Lateral Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Amyotrophic Lateral Sclerosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Amyotrophic Lateral Sclerosis Pipeline Therapeuetics Report 2024
DelveInsight's, "Amyotrophic Lateral Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It covers the Amyotrophic Lateral Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Amyotrophic Lateral Sclerosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Amyotrophic Lateral Sclerosis (ALS) Market Size, Trends & Share 2034
Market Overview: The Amyotrophic Lateral Sclerosis (ALS) market reached a value of US$ 494.1 Million in 2023 and expected to reach US$ 715.4 Million by 2034, exhibiting a growth rate (CAGR) of 3.4% during 2024-2034. The report offers a comprehensive analysis of the amyotrophic lateral sclerosis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available
Amyotrophic Lateral Sclerosis Pipeline Insight Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Amyotrophic Lateral Sclerosis Pipeline constitutes 90+ key companies continuously working towards developing 100+ Amyotrophic Lateral Sclerosis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight. In the Amyotrophic Lateral Sclerosis Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Amyotrophic
Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care. https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/ Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve